Dimitrios A Tsakiris
Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial.
Polymeris A, Karwacki G, Siepen B, Schaedelin S, Tsakiris D, Stippich C, Guzman R, Nickel C, Sprigg N, Kägi G, Vehoff J, Barinka F, Thilemann S, Maurer M, Wagner B, Traenka C, Gensicke H, De Marchis G, Bonati L, Fischer U, Z'Graggen W, Nedeltchev K, Wegener S, Baumgartner P, Engelter S, Seiffge D, Peters N, Lyrer P, TICH-NOAC Investigators. Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial. Stroke 2023; 54:2223-2234.
19.07.2023Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial.
19.07.2023Stroke 2023; 54:2223-2234
Polymeris Alexandros A, Karwacki Grzegorz M, Siepen Bernhard M, Schaedelin Sabine A, Tsakiris Dimitrios A, Stippich Christoph, Guzman Raphael, Nickel Christian H, Sprigg Nikola, Kägi Georg, Vehoff Jochen, Barinka Filip, Thilemann Sebastian, Maurer Marina, Wagner Benjamin, Traenka Christopher, Gensicke Henrik, De Marchis Gian Marco, Bonati Leo H, Fischer Urs, Z'Graggen Werner J, Nedeltchev Krassen, Wegener Susanne, Baumgartner Philipp, Engelter Stefan T, Seiffge David Julian, Peters Nils, Lyrer Philippe A, TICH-NOAC Investigators
Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage.
Seiffge D, Kägi G, Michel P, Fischer U, Béjot Y, Wegener S, Zedde M, Turc G, Cordonnier C, Sándor P, Rodier G, Zini A, Cappellari M, Schaedelin S, Polymeris A, Werring D, Thilemann S, Maestrini I, Berge E, Traenka C, Vehoff J, De Marchis G, Peters N, Sirimarco G, Bonati L, Arnold M, Lyrer P, De Maistre E, Luft A, Tsakiris D, Engelter S, Novel Oral Anticoagulants in Stroke Patients study group. Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage. Ann Neurol 2018; 83:451-459.
03.03.2018Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage.
03.03.2018Ann Neurol 2018; 83:451-459
Seiffge David Julian, Kägi Georg, Michel Patrik, Fischer Urs, Béjot Yannick, Wegener Susanne, Zedde Marialuisa, Turc Guillaume, Cordonnier Charlotte, Sándor Peter S, Rodier Gilles, Zini Andrea, Cappellari Manuel, Schaedelin Sabine A, Polymeris Alexandros A, Werring David J, Thilemann Sebastian, Maestrini Ilaria, Berge Eivind, Traenka Christopher, Vehoff Jochen, De Marchis Gian Marco, Peters Nils, Sirimarco Gaia, Bonati Leo H, Arnold Marcel, Lyrer Philippe A, De Maistre Emmanuel, Luft Andreas R, Tsakiris Dimitrios A, Engelter Stefan T, Novel Oral Anticoagulants in Stroke Patients study group
Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.
Seiffge D, Traenka C, Polymeris A, Thilemann S, Wagner B, Hert L, Delignette-Muller M, Gensicke H, Peters N, Nickel C, Stippich C, Sutter R, Marsch S, Fisch U, Guzman R, De Marchis G, Lyrer P, Bonati L, Tsakiris D, Engelter S. Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice. J Stroke 2017; 19:347-355.
06.09.2017Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.
06.09.2017J Stroke 2017; 19:347-355
Seiffge David Julian, Traenka Christopher, Polymeris Alexandros A, Thilemann Sebastian, Wagner Benjamin, Hert Lisa, Delignette-Muller Marie Laure, Gensicke Henrik, Peters Nils, Nickel Christian H, Stippich Christoph, Sutter Raoul, Marsch Stephan C, Fisch Urs, Guzman Raphael, De Marchis Gian Marco, Lyrer Philippe A, Bonati Leo H, Tsakiris Dimitrios A, Engelter Stefan T
Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera.
Meyer S, Steinmann E, Lehmann T, Muesser P, Passweg J, Skoda R, Tsakiris D. Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera. Biomed Res Int 2017; 2017:9876819.
18.06.2017Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera.
18.06.2017Biomed Res Int 2017; 2017:9876819
Meyer Sara C, Steinmann Eva, Lehmann Thomas, Muesser Patricia, Passweg Jakob R, Skoda Radek C, Tsakiris Dimitrios A
Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke.
Seiffge D, Traenka C, Polymeris A, Hert L, Fisch U, Peters N, De Marchis G, Guzman R, Nickel C, Lyrer P, Bonati L, Tsakiris D, Engelter S. Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke. J Thromb Thrombolysis 2017; 43:112-116.
01.01.2017Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke.
01.01.2017J Thromb Thrombolysis 2017; 43:112-116
Seiffge David Julian, Traenka Christopher, Polymeris Alexandros A, Hert Lisa, Fisch Urs, Peters Nils, De Marchis Gian Marco, Guzman Raphael, Nickel Christian H, Lyrer Philippe A, Bonati Leo H, Tsakiris Dimitrios A, Engelter Stefan T
Pre-analytical effects of pneumatic tube transport on impedance platelet aggregometry
Bolliger D, Seeberger M, Tanaka K, Dell-Kuster S, Gregor M, Zenklusen U, Grapow M, Tsakiris D, Filipovic M. Pre-analytical effects of pneumatic tube transport on impedance platelet aggregometry. Platelets 2009; 20:458-65.
01.11.2009Pre-analytical effects of pneumatic tube transport on impedance platelet aggregometry
01.11.2009Platelets 2009; 20:458-65
Bolliger Daniel, Seeberger Manfred D, Tanaka Kenichi A, Dell-Kuster Salome, Gregor Michael, Zenklusen Urs, Grapow Martin, Tsakiris Dimitrios A, Filipovic Miodrag